Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 186

Results For "SPI"

2737 News Found

Dr. Reddy's Laboratories acquires injectable product portfolio from Eton Pharma
News | June 27, 2022

Dr. Reddy's Laboratories acquires injectable product portfolio from Eton Pharma

Dr. Reddy's acquired the Eton portfolio for an upfront payment of approximately $5 million in cash, plus contingent payments of up to $45 million.


Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against omicron
News | June 27, 2022

Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against omicron

Both vaccine candidates demonstrated a favorable safety and tolerability profile similar to the Pfizer-BioNTech COVID-19 Vaccine


Mandaviya chairs high level meeting to review COVID-19 status
Policy | June 24, 2022

Mandaviya chairs high level meeting to review COVID-19 status

The Minister directed officials to continue to focus on surveillance and on Whole Genome Sequencing to scan for any possible mutation and also directed for monitoring hospitalizations due to COVID-19 and SARI/ILI cases


Novartis receives EC approval for Tabrecta for the treatment of non-small cell lung cancer
Drug Approval | June 24, 2022

Novartis receives EC approval for Tabrecta for the treatment of non-small cell lung cancer

Tabrecta is the number one prescribed targeted therapy for advanced NSCLC with alterations leading to METex14 skipping globally


MEI Pharma appoints Anne Frese as Chief People Officer
People | June 24, 2022

MEI Pharma appoints Anne Frese as Chief People Officer

Most recently, she served as chief human resources officer at Vyripharm Enterprises.


Rivaroxaban approved in Japan for patients with PAD after revascularisation
Drug Approval | June 24, 2022

Rivaroxaban approved in Japan for patients with PAD after revascularisation

It´s the first trial to demonstrate the benefits of dual pathway inhibition


Alembic Pharmaceuticals shows growth in May 2022
News | June 23, 2022

Alembic Pharmaceuticals shows growth in May 2022

Ex-Azithromycin has shown a growth of 8% and 14% in April 2022 and May 2022 respectively


Avni announces subscription model menstrual hygiene products
Healthcare | June 23, 2022

Avni announces subscription model menstrual hygiene products

The array available for a subscription includes popular products to make menstrual hygiene a regular practice and extend further affordability to its users


Briefs: Marksans Pharma and Alkem
News | June 22, 2022

Briefs: Marksans Pharma and Alkem

The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA.


AstraZeneca and Merck announces results from phase 3 PROpel trial of Lynparza
News | June 22, 2022

AstraZeneca and Merck announces results from phase 3 PROpel trial of Lynparza

LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)